文献速递骨软组织肉瘤与黑色素瘤

关注GARP:糖皮质激素如何释放T细胞对抗黑色素瘤

Mind the GARP: How Glucocorticoids Unleash T Cells against Melanoma.
PubMed 文献 · Cancer Discov · 2026-01-01

Earnshaw等发现由糖皮质激素受体(GR)激活驱动的肿瘤内在机制:GR下调糖蛋白A重复主导(GARP),抑制TGFβ信号,释放CD8+ T细胞发挥抗肿瘤活性。该机制增进了对GR塑造肿瘤免疫的理解,并为克服黑色素瘤等癌症的免疫检查点阻断耐药提供新途径。

要点

  • GR激活可下调肿瘤GARP,抑制TGFβ信号。
  • GARP下调释放CD8+ T细胞抗肿瘤活性。
  • 该机制为克服免疫检查点阻断耐药提供新思路。

核心结论

  • GR激活通过下调GARP抑制TGFβ信号并释放CD8+ T细胞抗肿瘤活性。

主要发现

  • GR激活驱动肿瘤内在机制,下调GARP并抑制TGFβ信号。
  • GARP下调释放CD8+ T细胞发挥抗肿瘤活性。

临床怎么用

  • 提示靶向GR-GARP-TGFβ轴可能克服黑色素瘤等癌症的免疫检查点阻断耐药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Earnshaw and colleagues discover a tumor-intrinsic mechanism driven by glucocorticoid receptor (GR) activation, in which GR downregulates glycoprotein A repetitions predominant (GARP), thereby inhibiting TGFβ signaling and releasing CD8+ T cells to exert their antitumor activity. This mechanistic insight significantly advances our understanding of how GR shapes tumor immunity and highlights new avenues for overcoming immune checkpoint blockade resistance in melanoma and other cancers. See related article by Earnshaw et al., p. 345.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Roest M, Padrão N, Zwart W, et al. Mind the GARP: How Glucocorticoids Unleash T Cells against Melanoma. Cancer Discov. 2026. PMID: 41645715. doi:10.1158/2159-8290.CD-25-2101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。